| Mark Anthony Foglietti, DO | |
|
22901 Millcreek Blvd, Suite 145, Beachwood, OH 44122-5728 | |
| (216) 292-6800 | |
| (216) 292-7775 |
| Full Name | Mark Anthony Foglietti |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 42 Years |
| Location | 22901 Millcreek Blvd, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205829686 | NPI | - | NPPES |
| 0550498 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 34003551F (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Pointe Hospital | Warrensville heights, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mark A. Foglietti Do Inc | 6901863893 | 2 |
News Archive
An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford shows.
3-N-butylphthalide, a green botanical medicine, is a successfully synthesized and stable chemical drug used for the treatment of ischemic stroke that has independent intellectual property rights in China.
PositiveID Corporation announced today that it has entered into a partnership with FIS™, one of the world's largest providers of banking and payments technology, to launch the Company's next generation Health Link personal health record ("Health Link").
A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.
› Verified 4 days ago
| Entity Name | Mark A. Foglietti Do Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831367507 PECOS PAC ID: 6901863893 Enrollment ID: O20041213000364 |
News Archive
An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford shows.
3-N-butylphthalide, a green botanical medicine, is a successfully synthesized and stable chemical drug used for the treatment of ischemic stroke that has independent intellectual property rights in China.
PositiveID Corporation announced today that it has entered into a partnership with FIS™, one of the world's largest providers of banking and payments technology, to launch the Company's next generation Health Link personal health record ("Health Link").
A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Anthony Foglietti, DO 22901 Millcreek Blvd, Suite 145, Beachwood, OH 44122-5728 Ph: (216) 292-6800 | Mark Anthony Foglietti, DO 22901 Millcreek Blvd, Suite 145, Beachwood, OH 44122-5728 Ph: (216) 292-6800 |
News Archive
An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford shows.
3-N-butylphthalide, a green botanical medicine, is a successfully synthesized and stable chemical drug used for the treatment of ischemic stroke that has independent intellectual property rights in China.
PositiveID Corporation announced today that it has entered into a partnership with FIS™, one of the world's largest providers of banking and payments technology, to launch the Company's next generation Health Link personal health record ("Health Link").
A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.
› Verified 4 days ago
Mrs. Mariana Rokitska, NP-C Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25501 Chagrin Blvd, Beachwood, OH 44122 Phone: 844-746-8537 | |
Gregory Malcolm Fedele, M.D. FACS Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25201 Chagrin Blvd, Suite 180, Beachwood, OH 44122 Phone: 216-464-1616 Fax: 216-464-1618 | |
Bryan J Michelow, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3733 Park East Dr, 107, Beachwood, OH 44122 Phone: 216-595-6800 Fax: 216-593-0414 | |
Dr. Kenneth Lee Arsham, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 23250 Chagrin Blvd, Suite #450, Beachwood, OH 44122 Phone: 216-831-1929 Fax: 216-831-1642 |